Otolaryngology Coding Alert

Correction:

Steroid Injection Doesn't Require Modifier 52

Report transtympanic injection as 69801

Modifier 52 is unnecessary on steroid injection claims of 69801.
 
Otolaryngology Coding Alert's April 2005 "You Be the Coder: How to Bill a Steroid Injection" erroneously added the reduced service indicator (modifier 52) to 69801 (Labyrinthotomy, with or without cryosurgery including other nonexcisional destructive procedures or perfusion of vestibuloactive drugs [single or multiple perfusions]; transcanal) for a transtympanic injection.
  
The American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) does not support the application of modifier 52 with the steroid injection. Otolaryngology Coding Alert concurs with the Academy's recommendation.

But remember, 69801 contains a 90-day global period. Therefore, you should not bill subsequent injections during this time.
 
You should, however, report the drugs, such as gentamicin (J1580, Injection, Garamycin, gentamicin, up to 80 mg).
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Otolaryngology Coding Alert

View All